Evidence map›Paper›PMID 39638802›Full record

ArticleNature communications2024

SARS-CoV-2 N protein recruits G3BP to double membrane vesicles to promote translation of viral mRNAs.

Siwen Long, Mykhailo Guzyk, Laura Perez Vidakovics, Xiao Han, Renhua Sun, Megan Wang, Marc D Panas, Egon Urgard, Jonathan M Coquet, Andres Merits and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pharmacological modulation of stress granulesFrontiers in pharmacology · 2026
    Review
  8. SARS-CoV-2 nsp14 induces the mCommunications biology · 2025
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siwen LongDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Mykhailo GuzykDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Laura Perez VidakovicsDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4283-812X
Xiao HanDepartment of Medicine Solna, Science for Life Laboratory, Karolinska Institute Solna, Solna, Sweden.
Renhua SunDepartment of Medicine Solna, Science for Life Laboratory, Karolinska Institute Solna, Solna, Sweden.ORCID 0000-0002-8203-4946
Megan WangDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-3000-3539
Marc D PanasDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7373-0341
Egon UrgardDepartment of Immunology and Microbiology, Leo Foundation Skin Immunology Research Centre, University of Copenhagen, Copenhagen, Denmark.
Jonathan M CoquetDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5967-4857
Andres MeritsInstitute of Bioengineering, University of Tartu, Tartu, Estonia.
Adnane AchourDepartment of Medicine Solna, Science for Life Laboratory, Karolinska Institute Solna, Solna, Sweden.ORCID 0000-0003-0432-710X
Gerald M McInerneyDivision of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. gerald.mcinerney@ki.se.ORCID 0000-0003-2257-7241

Funding

Cancerfonden (Swedish Cancer Society) 21 1779 PjStiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research) UKR22-0064Vetenskapsrådet (Swedish Research Council) 2020-04706
6 · The paper itself

Abstract

Ras-GTPase-activating protein SH3-domain-binding proteins (G3BP) are critical for the formation of stress granules (SGs) through their RNA- and ribosome-binding properties. SARS-CoV-2 nucleocapsid (N) protein exhibits strong binding affinity for G3BP and inhibits infection-induced SG formation soon after infection. To study the impact of the G3BP-N interaction on viral replication and pathogenesis in detail, we generated a mutant SARS-CoV-2 (RATA) that specifically lacks the G3BP-binding motif in the N protein. RATA triggers a stronger and more persistent SG response in infected cells, showing reduced replication across various cell lines, and greatly reduced pathogenesis in K18-hACE2 transgenic mice. At early times of infection, G3BP and WT N protein strongly colocalise with dsRNA and with non-structural protein 3 (nsp3), a component of the pore complex in double membrane vesicles (DMVs) from which nascent viral RNA emerges. Furthermore, G3BP-N complexes promote highly localized translation of viral mRNAs in the immediate vicinity of the DMVs and thus contribute to efficient viral gene expression and replication. In contrast, G3BP is absent from the DMVs in cells infected with RATA and translation of viral mRNAs is less efficient. This work provides a fuller understanding of the multifunctional roles of G3BP in SARS-CoV-2 infection.

Indexed as

Coronavirus Nucleocapsid ProteinsCOVID-19Poly-ADP-Ribose Binding ProteinsProtein BiosynthesisRNA HelicasesRNA, MessengerRNA Recognition Motif ProteinsRNA, ViralSARS-CoV-2Virus ReplicationAnimalsChlorocebus aethiopsDNA HelicasesHEK293 CellsHumansMiceCoronavirus Nucleocapsid ProteinsDNA HelicasesG3BP1 protein, humannucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA, MessengerRNA Recognition Motif ProteinsRNA, ViralViral Nonstructural Proteins

Identifiers

PMID39638802
PMCPMC11621422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.